drugset

drugset / Trial / NCT00265109

Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder

NCT00265109 ↗

Phase 4 Completed 17 enrolled Butler Hospital UCB Pharma · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the usefulness of a medication (Levetiracetam) for people with body dysmorphic disorder.

Timeline

Start: 2004-12
Primary completion: 2008-01
Completion: 2008-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Levetiracetam	Other / unclassified	—	—

Indications